Company Filing History:
2 out of 122 
2 out of 5 
2 out of 243 
Years Active: 2000-2011
Title: Alasdair Roderick MacLean: Innovator in Cancer Treatment
Introduction
Alasdair Roderick MacLean is a notable inventor based in Glasgow, GB. He has made significant contributions to the field of cancer treatment through his innovative research and development. With a total of 6 patents, MacLean has focused on utilizing mutant herpes simplex virus (HSV) as a potential anti-cancer agent.
Latest Patents
MacLean's latest patents include groundbreaking work on the treatment of melanoma using HSV mutant. This involves the use of a mutant herpes simplex virus that has a modification in the γ34.5 gene in the long repeat region (R), rendering the gene non-functional. His patents also cover the manufacture of medicaments and methods for testing cancer in mammals employing the HSV mutant. Additionally, he has developed methods for treating cancer using the same HSV mutant, emphasizing its potential as an anti-cancer agent.
Career Highlights
Throughout his career, MacLean has worked with esteemed institutions such as the University of Glasgow and Crusade Laboratories Limited. His work has been pivotal in advancing the understanding and treatment of cancer, particularly through innovative approaches involving viral therapies.
Collaborations
MacLean has collaborated with notable colleagues, including Susanne Moira Brown and Nigel William Fraser. These partnerships have contributed to the success of his research and the development of his patents.
Conclusion
Alasdair Roderick MacLean stands out as an influential inventor in the realm of cancer treatment. His innovative use of HSV mutants showcases the potential for new therapeutic approaches in oncology. His contributions continue to inspire advancements in medical research and treatment methodologies.